QSAR study of selective ligands for the thyroid hormone receptor β

Bioorganic & Medicinal Chemistry
2007.0

Abstract

In this paper, an accurate and reliable QSAR model of 87 selective ligands for the thyroid hormone receptor beta 1 (TRbeta1) was developed, based on theoretical molecular descriptors to predict the binding affinity of compounds with receptor. The structural characteristics of compounds were described wholly by a large amount of molecular structural descriptors calculated by DRAGON. Six most relevant structural descriptors to the studied activity were selected as the inputs of QSAR model by a robust optimization algorithm Genetic Algorithm. The built model was fully assessed by various validation methods, including internal and external validation, Y-randomization test, chemical applicability domain, and all the validations indicate that the QSAR model we proposed is robust and satisfactory. Thus, the built QSAR model can be used to fast and accurately predict the binding affinity of compounds (in the defined applicability domain) to TRbeta1. At the same time, the model proposed could also identify and provide some insight into what structural features are related to the biological activity of these compounds and provide some instruction for further designing the new selective ligands for TRbeta1 with high activity.

Knowledge Graph

Similar Paper

QSAR study of selective ligands for the thyroid hormone receptor β
Bioorganic & Medicinal Chemistry 2007.0
Convenient QSAR model for predicting the complexation of structurally diverse compounds with β-cyclodextrins
Bioorganic & Medicinal Chemistry 2009.0
QSAR study of imidazoline antihypertensive drugs
Bioorganic & Medicinal Chemistry 2008.0
Quantitative structure–activity relationship studies of a series of non-benzodiazepine structural ligands binding to benzodiazepine receptor
European Journal of Medicinal Chemistry 2008.0
Three-dimensional quantitative structure–selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2
European Journal of Medicinal Chemistry 2011.0
Development, Validation, and Use of Quantitative Structure−Activity Relationship Models of 5-Hydroxytryptamine (2B) Receptor Ligands to Identify Novel Receptor Binders and Putative Valvulopathic Compounds among Common Drugs
Journal of Medicinal Chemistry 2010.0
Predicting hERG activities of compounds from their 3D structures: Development and evaluation of a global descriptors based QSAR model
European Journal of Medicinal Chemistry 2011.0
A novel quantitative structure–activity relationship method to predict the affinities of MT3 melatonin binding site
European Journal of Medicinal Chemistry 2008.0
Impact of Induced Fit on Ligand Binding to the Androgen Receptor:  A Multidimensional QSAR Study To Predict Endocrine-Disrupting Effects of Environmental Chemicals
Journal of Medicinal Chemistry 2005.0
QSAR models for predicting enzymatic hydrolysis of new chemical entities in ‘soft-drug’ design
Bioorganic & Medicinal Chemistry 2009.0